DOCSLIB.ORG

Queuosine Deficiency in Eukaryotes Compromises Tyrosine Production Through Increased Tetrahydrobiopterin Oxidation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Queuosine Deficiency in Eukaryotes Compromises Tyrosine Production Through Increased Tetrahydrobiopterin Oxidation JBC Papers in Press. Published on April 12, 2011 as Manuscript M111.219576 The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.M111.219576 QUEUOSINE DEFICIENCY IN EUKARYOTES COMPROMISES TYROSINE PRODUCTION THROUGH INCREASED TETRAHYDROBIOPTERIN OXIDATION Tatsiana Rakovich‡, Coilin Boland‡, Ilana Bernstein§, Vimbai M. Chikwana¶, Dirk Iwata-Reuyl¶, and Vincent P. Kelly‡ From the ‡School of Biochemistry & Immunology, Trinity College Dublin, Dublin 2, Ireland, §School of Environmental & Life Sciences, University of Newcastle, Callaghan, NSW, 2308, Australia, and ¶Department of Chemistry, Portland State University, Portland, Oregon 97207 Running head: Queuosine deficiency leads to elevated dihydrobiopterin Address correspondence to: Vincent Kelly, Ph.D., School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, Ireland. Tel: +353-1-8963507; Fax: 81-298-53-7318; E-mail: [email protected] Queuosine is a modified pyrrolopyrimidine of complex carbohydrates to the provision of vital nucleoside found in the anticodon loop of micronutrients (1). Queuosine is an example of a transfer RNA acceptors for the amino acids micronutrient, synthesised exclusively by bacteria Downloaded from tyrosine, asparagine, aspartic acid, and but which, for poorly defined reasons, is utilised histidine. Since it is exclusively synthesised by by almost all eukaryotic species with the exception bacteria, higher eukaryotes must salvage of the baker’s yeast, S. cerevisiae (2). queuosine or its nucleobase queuine from food Bacterial queuosine biosynthesis occurs in two and the gut microflora. Previously, animals stages. Firstly, a series of five enzymatic steps www.jbc.org made deficient in queuine died within 18 days of convert guanosine triphosphate nucleoside (GTP) withdrawing tyrosine—a non-essential amino to the soluble 7-aminomethyl-7-deazaguanine acid—from the diet [Marks T, Farkas WR (preQ ) molecule. Subsequently, preQ is inserted 1 1 at IReL (Trinity College Dublin), on May 23, 2011 (1997) Biochem Biophys Res Commun 230:233- into the wobble position of tRNA containing a 7]. Here we show that human HepG2 cells GUN consensus sequence (tyr, asp, asn, his) by deficient in queuine and mice made deficient in means of the single enzyme species, tRNA guanine queuosine modified transfer RNA, by transglycosylase (TGT) and further remodeled in disruption of the tRNA guanine transglycosylae situ to queuosine (3). Eukaryotes must acquire (TGT) enzyme, are compromised in their ability queuosine or its free nucleobase, queuine, from to produce tyrosine from phenylalanine. This food and the gut-microflora. Curiously, both has similarities to the disease phenylketonuria, cytosolic and mitochondrial tRNA species are which arises from mutation in the enzyme modified by queuosine (2). The eukaryotic enzyme phenylalanine hydroxylase or from a decrease that performs this reaction, queuine tRNA in the supply of its cofactor tetrahydrobiopterin ribosyltransferase, has recently been identified as a (BH4). Immunoblot and kinetic analysis of liver heterodimeric complex, consisting of the from TGT deficient animals indicate normal eukaryotic homologue of the catalytic TGT subunit expression and activity of phenylalanine and a related protein called queuine tRNA hydroxylase. By contrast, BH4 levels are ribosyltransferase domain containing 1 (QTRTD1), significantly decreased in the plasma and both both of which localize to the mitochondria (4, 5). plasma and urine show a clear elevation in Studies on germ-free (axenic) mice maintained dihydrobiopterin, an oxidation product of BH4, on a chemically defined diet, provided clear despite normal activity of the salvage enzyme evidence that eukaryotes are non-autotrophic for dihydrofolate reductase. Our data suggest that queuosine biosynthesis (6). Unchallenged, these queuosine modification limits BH4 oxidation in animals appear normal. However, withdrawal of vivo and thereby potentially impacts on tyrosine from the diet resulted in symptoms of numerous physiological processes in eukaryotes. squinting, stiffness, lethargy, convulsion, and ultimately death after 18 days (7). Re- Bacteria and humans have co-evolved for millenia administration of either chemically synthesised and many examples exist of how various symbiotic queuine or tyrosine alone prevented the symptoms; and commensal partnerships contribute to human the latter result suggesting that tyrosine uptake and health and nutrition ranging from the metabolism utilisation is unaffected by queuine status. It has 1 Copyright 2011 by The American Society for Biochemistry and Molecular Biology, Inc. been long established that tyrosine is a non- Animals: Mice were bred and housed under essential amino acid in higher eukaryotes as it can specific pathogen-free conditions. Procedures were be synthesized from phenylalanine by the action of performed on mice at 6–8 weeks of age, unless the phenylalanine hydroxylase (PAH) enzyme. It otherwise stated, according to regulations and has been suggested therefore that the absence of guidelines of the Ethics Committee, Trinity queuine may affect the translation of the PAH College Dublin and the Irish Department of Health. enzyme leading to a dietary dependency on Tyrosine free chemically defined diet (AIN-76A tyrosine supply (2, 8). purified diet) was obtained from Harlan Teklad. In humans, tyrosine production occurs principally in the liver and kidney correlating with Cell Culture: HepG2 cells were purchased from the expression of the PAH enzyme (9). Deficiency the American Tissue Culture Collection and grown in PAH leads to the disease phenylketonuria, in an atmosphere of 5% CO2 at 37°C in the characterized by increased blood levels of following media: Dulbecco's modified Eagle's phenylalanine (referred to hyperphenylalaninemia) medium (DMEM) supplemented with 10% (v/v) and reduced levels of tyrosine. In performing its fetal bovine serum (DMEM-FBS) or 10% (v/v) Downloaded from reaction PAH requires molecular oxygen and BH4 horse serum (DMEM-HS), 2 mM L-glutamine, 1 cofactor (Fig. 1). BH4 is produced from GTP by mM sodium pyruvate, and penicillin/streptomycin the enzymes GTP cyclohydrolase I, 6-pyruvoyl- (50 U/0.1 mg/ml) or in Ultraculture™ serum free tetrahydropterin synthase and sepiapterin reductase. medium (Lonza) supplemented with 2 mM L- In generating BH4, other intermediary reactions at glutamine and penicillin/streptomycin (10 U/20 www.jbc.org the sepiapterin reductase step are performed by µg/ml). When required, chemically synthesized carbonyl reductase and member proteins of the queuine (a gift from Dr. Susumu Nishimura, aldo-keto reductase family (10). The BH4 cofactor Tsukuba University, Japan) was added at a final at IReL (Trinity College Dublin), on May 23, 2011 may also be recycled by the activity of two concentration of 300 nM. enzymes, pterin-4a-carbinolamine dehydratase and dihydropteridine reductase, which has particular Radiolabelled phenylalanine hydroxylase assay: importance for tyrosine biosynthesis in the liver. HepG2 cells were grown in serum-free (SF) Deficiency in any of the BH4 enzymes, with the medium, SF medium supplemented with queuine exception of sepiapterin reductase, causes (300nM) or in DMEM with 10% FBS. Intracellular hyperphenylalaninemia. Recent studies have tyrosine and phenylalanine were depleted by shown that BH4 is also highly susceptible to auto- incubation in SF medium not containing tyrosine oxidation in vivo producing the metabolite 7,8 or phenylalanine (Lonza; custom synthesis) and dihydrobiopterin (BH2), whose accumulation is supplemented with cyclohexamide (20µg/ml) with limited by the enzyme dihydrofolate reductase constant shaking at 70 rpm for 1 hour. (DHFR) through reduction of BH2 to BH4 (11). Subsequently, cells were washed and incubated in By extrapolation from the current data, the KRHL buffer (120 mM NaCl, 4.8 mM KCl, 10 tyrosine dependency of queuine deficient animals mM D-glucose, 2.5 mM CaCl2, 1.3 mM MgSO4, may relate to the loss of PAH activity or altered 2.5 mM Hepes, pH 7) containing 20 µM, 60 µM BH4 cofactor supply. In the present study, we and 100 µM L-[2,6-3H]- Phenylalanine (54 show that queuosine modification of tRNA, or Ci/mmol; Amersham) and 20 µg/ml hypothetically another unknown RNA substrate of cyclohexamide for 30 minutes with constant the queuine tRNA ribosyltranferase enzyme, as shaking. Duplicate wells for each experimental opposed to free queuine base, is required for point were used to determine cell protein content. normal tyrosine production in eukaryotes. Cells were solubilised with M-PER solution Decreased BH4 levels, concomitant with a marked (Pierce) and the protein concentration determined accumulation of BH2 suggests that oxidation of by Bradford assay (Bio-Rad). After 30 minutes, BH4 cofactor underlies the defect. medium was removed, cells were washed rapidly with ice-cold PBS and lysed in ice-cold 10% EXPERIMENTAL METHODS trichloroacetic acid (100 µl per well). Cells were scraped from the dish and the lysate centrifuged at 16,000 x g for 15 minutes. The supernatant was 2 stored at -70 oC until analysed. Intracellular PAH cDNA was cloned into the BamHI and SalI phenyalanine and tyrosine were measured by restriction sites of pMal-c2 (New England Biolabs) HPLC on a Zorbax 300SB-C18 column (Agilent) which was transformed in E.coli BL21 DE3 cells pre-equilibrated with Mobile Phase Buffer (100 Protein induction was performed by addition of 0.5 mM sodium phosphate pH 1.9, 300 µM octyl mM isopropyl-1-thio-β-D-galacto-pyranoside at sodium
Load more

Recommended publications
  • (12) United States Patent (10) Patent No.: US 6,822,071 B1 Stephens Et Al
    USOO6822071B1 (12) United States Patent (10) Patent No.: US 6,822,071 B1 Stephens et al. (45) Date of Patent: Nov. 23, 2004 (54) POLYPEPTIDES FROM CHLAMYDIA (56) References Cited PNEUMONIAE AND THEIR USE IN THE DIAGNOSIS, PREVENTION AND FOREIGN PATENT DOCUMENTS TREATMENT OF DISEASE WO 99/27105 * 6/1999 (75) Inventors: Richard S. Stephens, Orinda, CA (US); OTHER PUBLICATIONS Wayne Mitchell, San Francsico, CA Gerhold et al-BioEssays 18(12):973-981, 1996.* (US); Sue S. Kalman, Saratoga, CA Wells et al Journal of Leukocyte Biology 61(5):545-550, (US); Ronald Davis, Palo Alto, CA 1997.* (US) Russell et al Journal of Molecular Biology 244:33-350, 1994.* (73) Assignee: The Regents of the University of Rudinger et al., in “Peptide Hormones' Parsons, TA ets, California, Oakland, CA (US) University Park Press pp. 1–6, 1976.* Burgess et al, The Journal of Cell Biology, 111:2129-2138, Notice: Subject to any disclaimer, the term of this 1990.* patent is extended or adjusted under 35 Lazar et al, Molecular and Cellular Biology U.S.C. 154(b) by 0 days. 8(3):1247–1252, 1988.* Jobling et al, Mol-Microbiol. 5(7): 1755–67, 1991.* (21) Appl. No.: 09/438,185 Pir-68 Database Accession No. E72002 Kalmar et al. Apr. (22) Filed: Nov. 11, 1999 23, 1999.* (Under 37 CFR 1.47) * cited by examiner Primary Examiner Patricia A. Duffy Related U.S. Application Data (74) Attorney, Agent, or Firm Townsend and Townsend (60) Provisional application No. 60/128,606, filed on Apr. 8, and Crew 1999, and provisional application No.
    [Show full text]
  • Prolonging Healthy Aging: Longevity Vitamins and Proteins PERSPECTIVE Bruce N
    PERSPECTIVE Prolonging healthy aging: Longevity vitamins and proteins PERSPECTIVE Bruce N. Amesa,1 Edited by Cynthia Kenyon, Calico Labs, San Francisco, CA, and approved September 13, 2018 (received for review May 30, 2018) It is proposed that proteins/enzymes be classified into two classes according to their essentiality for immediate survival/reproduction and their function in long-term health: that is, survival proteins versus longevity proteins. As proposed by the triage theory, a modest deficiency of one of the nutrients/cofactors triggers a built-in rationing mechanism that favors the proteins needed for immediate survival and reproduction (survival proteins) while sacrificing those needed to protect against future damage (longevity proteins). Impairment of the function of longevity proteins results in an insidious acceleration of the risk of diseases associated with aging. I also propose that nutrients required for the function of longevity proteins constitute a class of vitamins that are here named “longevity vitamins.” I suggest that many such nutrients play a dual role for both survival and longevity. The evidence for classifying taurine as a conditional vitamin, and the following 10 compounds as putative longevity vitamins, is reviewed: the fungal antioxidant ergo- thioneine; the bacterial metabolites pyrroloquinoline quinone (PQQ) and queuine; and the plant antioxidant carotenoids lutein, zeaxanthin, lycopene, α-andβ-carotene, β-cryptoxanthin, and the marine carotenoid astaxanthin. Because nutrient deficiencies are highly prevalent in the United States (and elsewhere), appro- priate supplementation and/or an improved diet could reduce much of the consequent risk of chronic disease and premature aging. vitamins | essential minerals | aging | nutrition I propose that an optimal level of many of the known adverse health effects.
    [Show full text]
  • Preferential Import of Queuosine-Modified Trnas Into
    Published online 9 July 2021 Nucleic Acids Research, 2021, Vol. 49, No. 14 8247–8260 https://doi.org/10.1093/nar/gkab567 Preferential import of queuosine-modified tRNAs into Trypanosoma brucei mitochondrion is critical for organellar protein synthesis Sneha Kulkarni1,2, Mary Anne T. Rubio1,3,EvaHegedusov˝ a´ 1, Robert L. Ross4, Patrick A. Limbach 5, Juan D. Alfonzo3 and Zdenekˇ Paris 1,2,* 1Institute of Parasitology, Biology Centre, Czech Academy of Sciences, Ceskˇ eBud´ ejovice,ˇ Czech Republic, 2Faculty 3 of Science, University of South Bohemia, Ceskˇ eBud´ ejovice,ˇ Czech Republic, Department of Microbiology and The Downloaded from https://academic.oup.com/nar/article/49/14/8247/6318497 by guest on 01 October 2021 Center for RNA Biology, The Ohio State University, Columbus, OH, USA, 4Metabolomics Mass Spectrometry Core, Department of Cancer Biology, University of Cincinnati, Cincinnati, OH, USA and 5Rieveschl Laboratories for Mass Spectrometry, Department of Chemistry, University of Cincinnati, Cincinnati, OH, USA Received November 30, 2020; Revised May 28, 2021; Editorial Decision June 13, 2021; Accepted June 21, 2021 ABSTRACT sine (Q), a hypermodified 7-deaza-guanosine, is one of the most chemically intricate modifications described to date. Transfer RNAs (tRNAs) are key players in protein syn- Q is found at the wobble position 34 of tRNAs that contain thesis. To be fully active, tRNAs undergo extensive a5-GUN-3 anticodon sequence, where N represents any post-transcriptional modifications, including queuo- of the canonical nucleotides, which includes tRNAHisGUG, sine (Q), a hypermodified 7-deaza-guanosine present tRNAAspGUC, tRNAAsnGUU, tRNATyr GUA (3). Q is in the anticodon of several tRNAs in bacteria and eu- found in both bacteria and eukarya, and catalyzed by tRNA karya.
    [Show full text]
  • Discovery of Novel Bacterial Queuine Salvage Enzymes and Pathways in Human Pathogens
    Discovery of novel bacterial queuine salvage enzymes and pathways in human pathogens a,1 b,1 c,1 b d a Yifeng Yuan , Rémi Zallot , Tyler L. Grove , Daniel J. Payan , Isabelle Martin-Verstraete , Sara Sepic´ , Seetharamsingh Balamkundue, Ramesh Neelakandane, Vinod K. Gadie, Chuan-Fa Liue, Manal A. Swairjof,g, Peter C. Dedone,h,i, Steven C. Almoc, John A. Gerltb,j,k, and Valérie de Crécy-Lagarda,l,2 aDepartment of Microbiology and Cell Science, University of Florida, Gainesville, FL 32611; bInstitute for Genomic Biology, University of Illinois at Urbana–Champaign, Urbana, IL 61801; cDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461; dLaboratoire de Pathogénèse des Bactéries Anaérobies, Institut Pasteur et Université de Paris, F-75015 Paris, France; eSingapore-MIT Alliance for Research and Technology, Infectious Disease Interdisciplinary Research Group, 138602 Singapore, Singapore; fDepartment of Chemistry and Biochemistry, San Diego State University, San Diego, CA 92182; gThe Viral Information Institute, San Diego State University, San Diego, CA 92182; hDepartment of Biological Engineering and Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139; iCenter for Environmental Health Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139; jDepartment of Biochemistry, University of Illinois at Urbana–Champaign, Urbana, IL 61801; kDepartment of Chemistry, University of Illinois at Urbana–Champaign, Urbana, IL 61801; and lUniversity of Florida Genetics Institute, Gainesville, FL 32610 Edited by Tina M. Henkin, The Ohio State University, Columbus, OH, and approved August 1, 2019 (received for review June 16, 2019) Queuosine (Q) is a complex tRNA modification widespread in 1A. The TGT enzyme, which is responsible for the base ex- eukaryotes and bacteria that contributes to the efficiency and accuracy change, is the signature enzyme in the Q biosynthesis pathway.
    [Show full text]
  • Synthesis of Tritium Labeled Queuine, Preq1 and Related Azide Probes Toward Examining the Prevalence of Queuine
    Synthesis of Tritium Labeled Queuine, PreQ1 and Related Azide Probes Toward Examining the Prevalence of Queuine by Allen F. Brooks A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Medicinal Chemistry) in the University of Michigan 2012 Doctoral Committee: Research Professor Hollis D. Showalter, Co-Chair Associate Professor George A. Garcia, Co-Chair Professor Hashim M. Al-Hashimi Assistant Professor Garry D. Dotson Assistant Professor Matthew B. Soellner © Allen F. Brooks 2012 In memory of Edward and Lillian Pederson ii Acknowledgements With my remaining time short, it is appropriate to look back and thank those that supported me in my dissertation work either professionally or as a friend. First and foremost, I have to acknowledge my best friend from the program, Adam Lee. If it was not for the trip to the ACS meeting in Chicago, Adam and I likely would have never got to know each other. Luckily, fate arranged such an occurrence. If not for Adam’s friendship and the support of some others, I likely would have left the program in my second year. I also have to thank Jason Witek, an undergraduate who worked in the Showalter lab. We actually met during the Organic Mechanisms course, as he was in an academic program of his own design. The time we worked together in the lab was a productive one, and interestingly an amusing time as well. I also have to thank several other associates for their help in progressing my research as well as making time here more pleasant, those individuals being: Dr.
    [Show full text]
  • Queuine, a Bacterial Derived Hypermodified Nucleobase, Shows Protection in in Vitro Models of Neurodegeneration
    bioRxiv preprint doi: https://doi.org/10.1101/2021.01.20.427538; this version posted January 22, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Queuine, a bacterial derived hypermodified nucleobase, shows protection in in vitro models of neurodegeneration Patricia Richard1*, Xavier Manière2*, Lucie Kozlowski2, Hélène Guillorit2,3, Patrice Garnier2, Antoine Danchin4, Nicole C. McKnight1** 1 Stellate Therapeutics Inc., 101 Avenue of the Americas, JLABS @ NYC, New York, NY 10013 2 Stellate Therapeutics SAS, 47 rue de Montmorency, 75003, Paris, France 3 Institut de Génomique Fonctionnelle, 141 rue de la Cardonille, 34094, Montpellier, France 4 Kodikos Labs, Institut Cochin, 24 rue du Faubourg Saint-Jacques, 75014, Paris, France ** corresponding author Email: [email protected] * These authors contributed equally to this work 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.01.20.427538; this version posted January 22, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Growing evidence suggests that human gut bacteria, comprising the microbiome that communicates with the brain through the so-called ‘gut-brain-axis’, are linked to neurodegener- ative disorders. Imbalances in the microbiome of Parkinson’s disease (PD) and Alzheimer’s dis- ease (AD) patients have been detected in several studies. Queuine is a hypermodified nucleobase enriched in the brain and exclusively produced by bacteria and salvaged by humans through their gut epithelium. Queuine replaces guanine at the wobble position of tRNAs with GUN anticodons and promotes efficient cytoplasmic and mitochondrial mRNA translation.
    [Show full text]
  • Deficiency of Queuine, a Highly Modified Furine Base, in Transfer Rnas from Primary and Metastatic Ovarian Malignant Tumors in Women1
    [CANCER RESEARCH 54, 446X-4471. August 15, 19<M| Deficiency of Queuine, a Highly Modified Furine Base, in Transfer RNAs from Primary and Metastatic Ovarian Malignant Tumors in Women1 Wlodzimierz Baranowski,2 Guy Dirheimer, Jerzy Andrzej Jakowicki, and GérardKeith Second Clinic of Gynecological Surgery, Academy of Medicine, 8 Jaczewski Street, Lublin 20849. Poland fW. B., J. A. J.J, and Unité"Structure des Macromolécules Biologiques et Mécanismesde Reconnaissance, " Institut de Biologie Moléculaireet Cellulaire du CNRS, 15 rue RenéDescartes, Strasbourg 67084, France [G. D., G. K.] ABSTRACT queuine on their own despite its presence in their queuine family tRNAs. In mammals, queuine is provided by the intestinal flora or as The IUN As from rapidly growing tissues, particularly from neoplasia, a diet factor. Furthermore, in embryonic tissues and regenerating rat often exhibit queuine deficiency. In order to check whether different kinds liver (i.e., in rapidly growing tissues), the queuine family tRNAs are of ovarian tumors display queuine deficiencies we have analyzed tRNA partially queuine deficient (6, 9). Similar observations of queuine samples from 16 ovarian malignancies. The tRNAs from histologically normal myometrium (4 samples) and myoma (6 samples) were taken as deficiency have been made in queuine family tRNAs from placenta healthy tissue and benign tumor references. Queuine deficiency was de tissue despite the presence of a large amount of free queuine in the termined by an exchange assay using (8-'H]guanine and tRNA:guanine amniotic fluid (8, 10). It has in addition been observed that neoplastic transglycosylase from Escherìchiacoli. tissues very often exhibit significant deficiencies in the queuine con The mean values of queuine deficiencies in tRNAs were: 10.95 ±2.21 tent of queuine family tRNAs (9).
    [Show full text]
  • Synthetic Ligands for Preq1 Riboswitches Provide Structural and Mechanistic Insights Into Targeting RNA Tertiary Structure
    ARTICLE https://doi.org/10.1038/s41467-019-09493-3 OPEN Synthetic ligands for PreQ1 riboswitches provide structural and mechanistic insights into targeting RNA tertiary structure Colleen M. Connelly1, Tomoyuki Numata2,3, Robert E. Boer1, Michelle H. Moon1, Ranu S. Sinniah1, Joseph J. Barchi1, Adrian R. Ferré-D’Amaré 2 & John S. Schneekloth Jr. 1 1234567890():,; Riboswitches are naturally occurring RNA aptamers that regulate gene expression by binding to specific small molecules. Riboswitches control the expression of essential bacterial genes and are important models for RNA-small molecule recognition. Here, we report the discovery of a class of synthetic small molecules that bind to PreQ1 riboswitch aptamers. These molecules bind specifically and reversibly to the aptamers with high affinity and induce a conformational change. Furthermore, the ligands modulate riboswitch activity through tran- scriptional termination despite no obvious chemical similarity to the cognate ligand. X-ray crystallographic studies reveal that the ligands share a binding site with the cognate ligand but make different contacts. Finally, alteration of the chemical structure of the ligand causes changes in the mode of RNA binding and affects regulatory function. Thus, target- and structure-based approaches can be used to identify and understand the mechanism of synthetic ligands that bind to and regulate complex, folded RNAs. 1 Chemical Biology Laboratory, National Cancer Institute, Frederick, MD 21701, USA. 2 Biochemistry and Biophysics Center, National Heart, Lung and Blood Institute, Bethesda, MD 20892, USA. 3 Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki 305-8566, Japan. These authors contributed equally: Colleen M.
    [Show full text]
  • Protection of the Queuosine Biosynthesis Enzyme Quef from Irreversible Oxidation by a Conserved Intramolecular Disulfide
    biomolecules Article Protection of the Queuosine Biosynthesis Enzyme QueF from Irreversible Oxidation by a Conserved Intramolecular Disulfide Adeba Mohammad 1, Adriana Bon Ramos 2, Bobby W. K. Lee 2, Spencer W. Cohen 2, Maryam K. Kiani 1, Dirk Iwata-Reuyl 2, Boguslaw Stec 3 and Manal A. Swairjo 1,3,* 1 Graduate College of Biomedical Sciences, Western University of Health Sciences, 309 E. Second Street, Pomona, CA 91766, USA; [email protected] (A.M.); [email protected] (M.K.K.) 2 Department of Chemistry, Portland State University, P.O. Box 751, Portland, OR 97207, USA; [email protected] (A.B.R.); [email protected] (B.W.K.L.); [email protected] (S.W.C.); [email protected] (D.I.-R.) 3 Department of Chemistry and Biochemistry, San Diego State University 5500 Campanile Drive, San Diego, CA 92182, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-619-206-3864 Academic Editor: Jürg Bähler Received: 10 January 2017; Accepted: 10 March 2017; Published: 16 March 2017 Abstract: QueF enzymes catalyze the nicotinamide adenine dinucleotide phosphate (NADPH)-dependent reduction of the nitrile group of 7-cyano-7-deazaguanine (preQ0) to 7-aminomethyl-7-deazaguanine (preQ1) in the biosynthetic pathway to the tRNA modified nucleoside queuosine. The QueF-catalyzed reaction includes formation of a covalent thioimide intermediate with a conserved active site cysteine that is prone to oxidation in vivo. Here, we report the crystal structure of a mutant of Bacillus subtilis QueF, which reveals an unanticipated intramolecular disulfide formed between the catalytic Cys55 and a conserved Cys99 located near the active site.
    [Show full text]
  • Prokaryotic Transcription Regulation by the Nascent RNA Elements
    pISSN 2288-6982 l eISSN 2288-7105 Biodesign https://doi.org/10.34184/kssb.2020.8.2.33 MINI REVIEW P 33-40 Prokaryotic transcription regulation by the nascent RNA elements Seungha Hwang†, Jimin Lee† and Jin Young Kang* Department of Chemistry, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea *Correspondence: [email protected] †These authors contributed equally to this work. Transcription regulation by cis-acting elements such as DNA and RNA has not been investigated much compared to that of trans-acting elements like transcription factors because most cis-elements are much larger and more flexible than protein factors. Consequently, it was challenging to recapitulate the function of cis-elements in a reduced system for in vitro assays. However, the recent cryo-electron microscopy (cryo-EM) made it possible to study the effect of nascent RNA elements to the transcription in combination with biochemical experiments as cryo-EM does not require crystallization and tolerates heterogeneity to an extent. In this review, we briefly described the current model on prokaryotic transcriptional pausing based on the crystal and cryo-EM structures of RNA polymerases in different contexts, including an RNA hairpin pause. We then introduced two other nascent RNA elements that modulate transcription – preQ1 riboswitch and HK022 put RNA. Understanding the function of the RNA elements to transcription will deepen our understanding of the fundamental mechanism transcription and provide the structural basis for drug discovery as well as bioresearch tool development. INTRODUCTION synthesis is initiated (Tomsic et al., 2001). As the nascent RNA Transcription is an essential cellular process that transfers the is elongated, the 3’-end of the transcript makes clashes with a genetic information engraved in DNA to RNA transcripts to make loop (named “σ finger”) from the σ factor.
    [Show full text]
  • 27Th Trna Conference-Abstractsbook-3
    P1.1 The protein-only RNase P PRORP1 interacts with the nuclease MNU2 in Arabidopsis mitochondria G. Bonnard, M. Arrivé, A. Bouchoucha, A. Gobert, C. Schelcher, F. Waltz, P. Giegé Institut de biologie moléculaire des plantes, CNRS, Université de Strasbourg, Strasbourg, France The essential endonuclease activity that removes 5’ leader sequences from transfer RNA precursors is called RNase P. While ribonucleoprotein RNase P enzymes containing a ribozyme are found in all domains of life, another type of RNase P called “PRORP”, for “PROtein-only RNase P”, only composed of protein occurs in a wide variety of eukaryotes, in organelles and the nucleus. Although PRORP proteins function as single subunit enzymes in vitro, we find that PRORP1 occurs in protein complexes and is present in polysome fractions in Arabidopsis mitochondria. The analysis of immuno- precipitated protein complexes identifies proteins involved in mitochondrial gene expression processes. In particular, direct interaction is established between PRORP1 and MNU2 another mitochondrial nuclease involved in RNA 5’ processing. A specific domain of MNU2 and a conserved signature of PRORP1 are found to be directly accountable for this protein interaction. Altogether, results reveal the existence of an RNA 5’ maturation complex in Arabidopsis mitochondria and suggest that PRORP proteins might cooperate with other gene expression regulators for RNA maturation in vivo. 111 P1.2 CytoRP, a cytosolic RNase P to target TLS-RNA phytoviruses 1 1 2 1 A. Gobert , Y. Quan , I. Jupin , P. Giegé 1Institut de biologie moléculaire des plantes, CNRS, Université de Strasbourg, Strasbourg, France 1Institut Jacques Monod, CNRS, Université Paris Diderot, Paris, France In plants, PRORP enzymes are responsible for RNase P activity that involves the removal of the 5’ extremity of tRNA precursors.
    [Show full text]
  • MODOMICS: a Database of RNA Modification Pathways. 2017 Update
    Published online 2 November 2017 Nucleic Acids Research, 2018, Vol. 46, Database issue D303–D307 doi: 10.1093/nar/gkx1030 MODOMICS: a database of RNA modification pathways. 2017 update Pietro Boccaletto1,†, Magdalena A. Machnicka1,2,†, Elzbieta Purta1,Pawe-lPiatkowski˛ 1, B-lazej˙ Baginski´ 1, Tomasz K. Wirecki1,Valerie´ de Crecy-Lagard´ 3, Robert Ross4,Patrick A. Limbach4, Annika Kotter5, Mark Helm5 and Janusz M. Bujnicki1,6,* 1Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology in Warsaw, ul. Ks. Trojdena 4, PL-02-109 Warsaw, Poland, 2Institute of Informatics, University of Warsaw, Banacha 2, PL-02-097 Warsaw, Poland, 3Microbiology and Cell Science Department, University of Florida, Gainesville, FL 32611, USA, 4Department of Chemistry, Rieveschl Laboratories for Mass Spectrometry, University of Cincinnati, Cincinnati, OH 45221, USA, 5Institut fur¨ Pharmazie und Biochemie, Johannes Gutenberg-Universitat,¨ Staudinger Weg 5, D-55128 Mainz, Germany and 6Faculty of Biology, Adam Mickiewicz University, ul. Umultowska 89, PL-61-614 Poznan, Poland Received September 15, 2017; Revised October 15, 2017; Editorial Decision October 16, 2017; Accepted October 18, 2017 ABSTRACT for basic biological processes [review: (1)]. Now we know that 163 post-transcriptional modifications of RNA intro- MODOMICS is a database of RNA modifications duce a functional diversity that allows the four basic ribonu- that provides comprehensive information concern- cleotide residues to gain diverse functions, akin to those of ing the chemical structures of modified ribonucleo- side chains of amino acid residues, which may be e.g., po- sides, their biosynthetic pathways, the location of lar, charged, aliphatic or aromatic. Modifications can di- modified residues in RNA sequences, and RNA- rectly influence RNA structure, by promoting or disrupt- modifying enzymes.
    [Show full text]